Page last updated: 2024-08-25

mopidralazine and Hypertension, Renal

mopidralazine has been researched along with Hypertension, Renal in 2 studies

*Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldoli, E; Bellasio, E; Campi, A; Di Mola, N1
Baldoli, E; Bianchi, G; Corsico, N; Di Francesco, GF1

Other Studies

2 other study(ies) available for mopidralazine and Hypertension, Renal

ArticleYear
Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:8

    Topics: Animals; Antihypertensive Agents; Dogs; Heart Rate; Hydralazine; Hypertension; Hypertension, Renal; Mutagenicity Tests; Pyridazines; Pyrroles; Rats

1984
Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:5

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Avoidance Learning; Dogs; Hemodynamics; Hexobarbital; Hypertension, Renal; Indomethacin; Injections, Intravenous; Male; Pentylenetetrazole; Postural Balance; Pyridazines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sleep; Species Specificity; Vasodilator Agents

1985